PE20001021A1 - Combinacion de un anti ep-cam con un agente quimioterapico - Google Patents
Combinacion de un anti ep-cam con un agente quimioterapicoInfo
- Publication number
- PE20001021A1 PE20001021A1 PE1999000745A PE00074599A PE20001021A1 PE 20001021 A1 PE20001021 A1 PE 20001021A1 PE 1999000745 A PE1999000745 A PE 1999000745A PE 00074599 A PE00074599 A PE 00074599A PE 20001021 A1 PE20001021 A1 PE 20001021A1
- Authority
- PE
- Peru
- Prior art keywords
- cam
- antigen
- cells
- antibody
- combination
- Prior art date
Links
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 abstract 2
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 abstract 2
- -1 MITOMYYCIN Chemical compound 0.000 abstract 2
- 190000008236 CARBOPLATIN Chemical compound 0.000 abstract 1
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 abstract 1
- 201000009030 Carcinoma Diseases 0.000 abstract 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 abstract 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 abstract 1
- 229930012538 Paclitaxel Natural products 0.000 abstract 1
- 229960004562 carboplatin Drugs 0.000 abstract 1
- 239000012829 chemotherapy agent Substances 0.000 abstract 1
- 229960004316 cisplatin Drugs 0.000 abstract 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 229960003668 docetaxel Drugs 0.000 abstract 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 abstract 1
- 229960001156 mitoxantrone Drugs 0.000 abstract 1
- 229960001756 oxaliplatin Drugs 0.000 abstract 1
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 abstract 1
- 229960001592 paclitaxel Drugs 0.000 abstract 1
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 abstract 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
- UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 abstract 1
- 229960000303 topotecan Drugs 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9816280.3A GB9816280D0 (en) | 1998-07-27 | 1998-07-27 | Antibody combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001021A1 true PE20001021A1 (es) | 2000-10-10 |
Family
ID=10836207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000745A PE20001021A1 (es) | 1998-07-27 | 1999-07-26 | Combinacion de un anti ep-cam con un agente quimioterapico |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR020631A1 (fr) |
| CO (1) | CO5090883A1 (fr) |
| GB (1) | GB9816280D0 (fr) |
| MA (1) | MA26665A1 (fr) |
| PE (1) | PE20001021A1 (fr) |
-
1998
- 1998-07-27 GB GBGB9816280.3A patent/GB9816280D0/en not_active Ceased
-
1999
- 1999-07-23 MA MA25699A patent/MA26665A1/fr unknown
- 1999-07-26 CO CO99046956A patent/CO5090883A1/es unknown
- 1999-07-26 PE PE1999000745A patent/PE20001021A1/es not_active Application Discontinuation
- 1999-07-26 AR ARP990103667 patent/AR020631A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO5090883A1 (es) | 2001-10-30 |
| AR020631A1 (es) | 2002-05-22 |
| GB9816280D0 (en) | 1998-09-23 |
| MA26665A1 (fr) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRPK20041072B3 (hr) | Primjena docetaxela/doxorubicina/ciklofosfamida uadjuvantnoj terapiji karcinoma dojke i jajnika | |
| MX9306924A (es) | Composiciones antitumorales que contienen derivados de taxano. | |
| PA8479201A1 (es) | Derivados del acido hidroxi-pipecolato hidroxamico | |
| AR049305A1 (es) | Método para tratar cancer resistente al platino con un anticuerpo her2 y un agente quimioterapéutico:gemcitabina | |
| MXPA05011755A (es) | Composiciones y metodos para inmunoterapia especifica de tumor wilms 1. | |
| PE20091328A1 (es) | Formulacion de anticuerpo | |
| DK0674630T3 (da) | 7-Halogen- og 7beta,8beta-methano-taxoler, antineoplastisk anvendelse og farmaceutiske præparater indeholdende dem | |
| UY28081A1 (es) | Administracinn combinada de una indolinona con un agente quimioterapcutico para trastornos de proliferacinn celular | |
| GB1351238A (en) | Clathrate prostaglandins and compositions containing same | |
| ATE121735T1 (de) | 2,4-diaminochinazolin-derivate, um die antitumorwirkung zu erhöhen. | |
| AR031250A1 (es) | Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon | |
| NZ726365A (en) | Combinations for treating cancers | |
| DK0767786T3 (da) | 7-ether-taxol-analoge, antineoplastisk anvendelse deraf og farmaceutiske præparater indeholdende disse forbindelser | |
| ES8203324A1 (es) | Procedimiento para la fabricacion de compuestos antitumora- les a base de platino | |
| EP1667716B8 (fr) | Mise en evidence d'une expression surfacielle du cd44 par la cytotoxicite de cellules | |
| ATE269700T1 (de) | Verwendung von docetaxel für die behandlung von hepatozelluläre krebs | |
| PE20001021A1 (es) | Combinacion de un anti ep-cam con un agente quimioterapico | |
| DE69815100D1 (de) | Zusammensetzungen, die dolastatin-15-analoge in kombination mit taxane und dessen derivaten enthalten | |
| KR960700734A (ko) | 사람 암에 대한 시스플래틴/타목시펜 배합 치료(Combination cisplatin/tamoxifen therapy for human cancers) | |
| CY1111813T1 (el) | Αντικαρκινικο εμβολιο που περιλαμβανει αλλογονιδιακα ή ξενογονιδιακα καρκινικα κυτταρα | |
| PH12021550815A1 (en) | New combination solution for treating chemotherapy refractory cancer | |
| BE899987A (fr) | Nouvelles compositions pharmaceutiques antitumorales. | |
| USD117261S (en) | Design fob a dress ensemble | |
| WO2021118328A3 (fr) | Composés théranostiques anticancéreux ayant une spécificité de carcinome hépatocellulaire | |
| MX2024012432A (es) | Tratamiento de tumores solidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |